Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina (NASDAQ:ILMN) will release first quarter 2026 financial results after market close on Thursday, April 30, 2026. A conference call and live webcast with CEO Jacob Thaysen, PhD, and CFO Ankur Dhingra will follow at 1:30 pm PT / 4:30 pm ET. A replay will be posted on the company's investor website and remain available for at least 30 days.
Details
News Market Reaction – ILMN
On Apr 10, the first trading day after this news, ILMN closed 2.22% below the previous close.
Data tracked by StockTitan Argus for the Apr 10 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.
Conference Call Details
The conference call will begin at 1:30 pm Pacific Time (4:30 pm Eastern Time) on Thursday, April 30, 2026. Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link - https://illumina-earnings-call-q1-2026.open-exchange.net/. To ensure timely connection, please join at least ten minutes before the scheduled start of the call.
A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Investors:
Conor McNamara
+1.858.291.6421
ir@illumina.com
Media:
Christine Douglass
pr@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-announce-first-quarter-2026-financial-results-on-thursday-april-30-2026-302737292.html
SOURCE Illumina, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.